News International Medical
Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains

Aug. 28, 2025, London, England and Neumünster, Germany — Tilray Medical has announced three new EU-GMP certified medical cannabis strain offerings for patients in Germany: Good Supply Cannabisblüten THC 22 IIM, Good Supply Cannabisblüten THC 25 MMK, and Good Supply Cannabisblüten THC 18 LLD.

Each product will be available in 15 g and 500 g sizes to meet diverse patient and pharmacy needs under Germany’s medical framework.

“At Tilray, our unwavering commitment to global medical cannabis leadership is driven by our dedication to patient care and advancing healthcare standards worldwide,” said Rajnish Ohri, managing director, international, Tilray Brands, in a media release. “By introducing these new Good Supply strains to the German market, we are not only expanding access to premium, EU-GMP certified options for physicians and patients, but also reaffirming our role as a trusted partner in medical cannabis across continents. Our robust international platform and strong distribution network empower us to deliver consistent quality and reliable supply—ensuring that those in need have access to safe, effective medical choices.”

Good Supply Cannabisblüten THC 22 IIM will be available beginning of September. Good Supply Cannabisblüten THC 25 MMK launches September 19, and Good Supply Cannabisblüten THC 18 LLD will follow at the end of September or early October. All three strains will be offered in 15 g jars for patients and 500 g packs for pharmacies.

Tilray Medical supplies EU‑GMP medical cannabis to pharmacies across Germany, where products are dispensed by prescription and supported by Tilray’s German logistics and distribution capabilities. These new strains expand the Good Supply portfolio, recognized as one of Canada’s top cannabis brands for its consistent quality and accessible formats, now tailored for German medical use.